T. Schneider / Shutterstock.com
6 October 2022AmericasMuireann Bolger
DNA test-maker demands $817m triple damages in patent win
Dispute against LabCorp claims wilful infringement | Plaintiff has also sued Illumina, Roche and Myriad in separate cases.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
27 May 2021 Illumina and Roche-owned Ariosa Diagnostics filed a joint stipulation asking the US Supreme Court to dismiss a case concerning the eligibility of Illumina’s DNA testing patents.
Americas
27 May 2020 Protein engineering company Codexis has accused competitor Codex DNA of trademark infringement through the use of a “virtually identical” mark.
Editor's picks
Editor's picks
Big Pharma
27 May 2021 Illumina and Roche-owned Ariosa Diagnostics filed a joint stipulation asking the US Supreme Court to dismiss a case concerning the eligibility of Illumina’s DNA testing patents.
Americas
27 May 2020 Protein engineering company Codexis has accused competitor Codex DNA of trademark infringement through the use of a “virtually identical” mark.
Big Pharma
27 May 2021 Illumina and Roche-owned Ariosa Diagnostics filed a joint stipulation asking the US Supreme Court to dismiss a case concerning the eligibility of Illumina’s DNA testing patents.
Americas
27 May 2020 Protein engineering company Codexis has accused competitor Codex DNA of trademark infringement through the use of a “virtually identical” mark.